Our second hypothesis, that during XRNT treatment, heroin-dependent patients will show a decrease in striatal DAT binding compared to baseline and that this decrease is associated with an increase in anhedonia and depression, was not confirmed. Here, SLC6A3 is linked to depressive symptom measurement.